Pharmacist terror Redcare continues to develop unabated | FAZ | EUROtoday

After the publication of gross sales figures at first of the yr, the share worth of the net pharmacy Redcare Pharmacy rose sharply. The paper rose in worth by a seventh in early buying and selling and was one of many greatest day by day winners within the common worth index M-Dax. Redcare with its primary model Shop Apotheke elevated gross sales by 18 % to 848 million euros within the first quarter of the yr. The firm introduced this on Wednesday.

Redcare generates nearly all of its gross sales in Germany, however relies in Sevenum, the Netherlands, close to the border as a result of companies are additionally allowed to function pharmacies within the neighboring nation. The firm sees itself as Europe’s largest distributor of prescription drugs and has far overtaken the trade pioneer Docmorris.

The digital competitor is unpopular amongst pharmacists in conventional retail. Retail pharmacists declare that they’re the one ones who supply sufferers sufficient recommendation. Redcare counters this: its specialist employees of greater than 150 pharmacists and pharmaceutical-technical assistants use the interior affected person info system to acknowledge potential interactions, double prescriptions or incorrect dosages even higher than standard pharmacies and make contact with the shopper or physician if essential.

Online retailers have already made vital inroads within the enterprise of over-the-counter medicines: According to trade associations, Redcare and its rivals already occupy a fifth to 1 / 4 of the German market. The scenario is totally different with medicines which are solely obtainable with a prescription: As lengthy as sufferers obtained their prescription on paper, they needed to ship it to on-line suppliers by letter, which suggests a excessive threshold. Electronic prescriptions have not too long ago turn out to be binding for these with statutory medical health insurance in Germany; You can now redeem it on the pharmacy or on-line.

The development spurt for Redcare comes from the prescribed drugs enterprise, albeit from a decrease degree. Their gross sales elevated by 55 % in Germany in comparison with the identical quarter final yr and by 35 % throughout international locations. At the identical time, analysts are taking note of whether or not the corporate can preserve the expansion charges within the non-prescription section: its revenues rose by a tenth, and at 533 million euros it nonetheless accounts for almost all of gross sales.

The share value 40.70 euros in early buying and selling. Its worth had fallen sharply over the previous twelve months; Most not too long ago, originally of March, a cautious outlook clouded the temper. Even after Wednesday’s worth bounce, the inventory has misplaced greater than a 3rd of its worth this yr, or two-thirds in comparison with the place it was a yr in the past. Redcare will current the interim report together with revenue figures on May sixth.